Chai for Cancer USA is back for a third year, and we’re building on the success of last year’s campaign, which established a program in India in partnership with Friends of Max, our local patient support arm, to help patients with one of their greatest needs – diagnostic testing. This was all made possible thanks to our generous supporters and our campaign sponsor, Choice Organic Teas!
This year, we have the opportunity to help more patients in need by raising additional funding for this program, and we need your help ensure people in India who are facing cancer get the lifesaving care they require!
How can you help? Take the Chai Five challenge to raise awareness of the needs of cancer survivors while raising funds for their support! What is “Chai Five”? The Chai Five is a list of five simple actions you can take to support people in India who are facing a cancer diagnosis.
When you take the first action of the Chai Five challenge with a gift to support Chai for Cancer USA, you are giving a cancer patient access to the diagnostic test that monitors their disease, and also helping them gain access to the free, lifesaving treatment they receive through The Max Foundation.
Join us in raising a cup of chai to help those facing cancer in India – donate today to take the first action of the Chai Five challenge!
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 27 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Read the story of Alassane, a leukemia patient from Senegal now receiving a lifesaving second-line medication through our Max Access Solutions, and the incredible 700km “last mile” journey he must make to access the treatment.
A “cold-chain” product must remain within a specific temperature range at all times. On days- or weeks-long international shipments, it’s especially challenging (and expensive) to keep medicine at a constant temperature. Despite the inherent challenges, adding cold-chain capability is well worth the effort for the patients we support. By doing so, The Max Foundation will be able to better meet the needs of patients who are unresponsive to tablet therapies.
Dr. Jayasree Iyer, Executive Director of the Access to Medicine Foundation (ATMF), sits down with The Max Foundation and answers seven questions about the Access to Medicine Index, emerging trends in treatment access, and the role of collaborative access initiatives in treating chronic diseases.
